Reply letter regarding seroconversion of hepatitis B surface antigen in a successful long-term immune cohort

Hum Vaccin Immunother. 2021 Aug 3;17(8):2775-2776. doi: 10.1080/21645515.2021.1897488. Epub 2021 Apr 14.

Authors

Zhigang Zheng^{1

2}, Qing-Lei Zeng^{1

2}, Yi-Hua Zhou^{1

2}

Affiliations

¹ Department of Epidemiology and Statistic, School of Public Health, Guangxi Medical University, Nanning, China.
² Guangxi Key Laboratory for the Prevention and Control of Viral Hepatitis, Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control, Nanning, China.

No abstract available

Publication types

Comment

MeSH terms

Cohort Studies
Hepatitis B Surface Antigens*
Hepatitis B e Antigens
Hepatitis B, Chronic* / therapy
Humans
Seroconversion

Substances

Hepatitis B Surface Antigens
Hepatitis B e Antigens